Novobay Biotechnology Company Limited
Rooted in Hong Kong, Connected to the World — Building the Future of Precision Medicine
Leveraging the booming growth of China's innovative pharmaceutical industry, Novobay uses Hong Kong as a strategic hub to build a full-chain service platform for precision medicine — integrating technology transfer, academic collaboration, and global empowerment. We are committed to being the bridge connecting China's and global medical innovation.
Oncology Molecular Diagnostics · NMPA Class III
Automated molecular diagnostic system with 96% sensitivity, 98.7% specificity. Results in ~3.5 hours.
Long-Read Genomic Sequencing
Next-generation single-molecule sequencing. No PCR required. Ultra-long reads with real-time analysis.
DNA Methylation Aging Test
Based on DNA methylation gold standard. 18 organ clocks. Non-invasive saliva sampling.